{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:29:24Z","timestamp":1782361764677,"version":"3.54.5"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.3816\/clc.2009.n.015","type":"journal-article","created":{"date-parts":[[2009,4,11]],"date-time":"2009-04-11T21:01:57Z","timestamp":1239483717000},"page":"118-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"title":["DNA Repair Gene Polymorphisms Predict Favorable Clinical Outcome in Advanced Non\u2013Small-Cell Lung Cancer"],"prefix":"10.3816","volume":"10","author":[{"given":"Aristea","family":"Kalikaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Vassalou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Souglakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Voutsina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Georgoulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Mavroudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CLC.2009.n.015_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/01.mcp.0000166590.03042.56","article-title":"The treatment of advanced non-small cell lung cancer","volume":"11","author":"Spiro","year":"2005","journal-title":"Curr Opin Pulm Med"},{"key":"10.3816\/CLC.2009.n.015_bib2","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1200\/JCO.2001.19.13.3210","article-title":"Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non\u2013small-cell lung cancer: a Southwest Oncology Group trial","volume":"19","author":"Kelly","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLC.2009.n.015_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJMoa011954","article-title":"Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer","volume":"346","author":"Schiller","year":"2002","journal-title":"N Engl J Med"},{"key":"10.3816\/CLC.2009.n.015_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1023\/A:1011083429704","article-title":"Glutathione content is correlated with the sensitivity of lines of PC12 cells to cisplatin without a corresponding change in the accumulation of platinum","volume":"219","author":"Ikeda","year":"2001","journal-title":"Mol Cell Biochem"},{"key":"10.3816\/CLC.2009.n.015_bib5","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1006\/bbrc.2001.5399","article-title":"Reversal of cisplatin and multidrug resistance by ribozyme-mediated glutathione suppression","volume":"286","author":"Nagata","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.3816\/CLC.2009.n.015_bib6","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1349-7006.2002.tb02482.x","article-title":"Significance of nuclear glutathione S-transferase pi in resistance to anti-cancer drugs","volume":"93","author":"Goto","year":"2002","journal-title":"Jpn J Cancer Res"},{"key":"10.3816\/CLC.2009.n.015_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/carcin\/19.2.275","article-title":"Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution","volume":"19","author":"Watson","year":"1998","journal-title":"Carcinogenesis"},{"key":"10.3816\/CLC.2009.n.015_bib8","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.1432-1033.1994.00893.x","article-title":"Naturally occurring human glutathione S-transferase GSTP1-1 isoforms with isoleucine and valine in position 104 differ in enzymic properties","volume":"224","author":"Zimniak","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.3816\/CLC.2009.n.015_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3109\/10409239509083491","article-title":"The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance","volume":"30","author":"Hayes","year":"1995","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.3816\/CLC.2009.n.015_bib10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/annonc\/mdj135","article-title":"Polymorphisms in DNA repair genes modulate survival in cisplatin\/gemcitabine-treated non-small-cell lung cancer patients","volume":"17","author":"de las Penas","year":"2006","journal-title":"Ann Oncol"},{"key":"10.3816\/CLC.2009.n.015_bib11","first-page":"604","article-title":"Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans","volume":"58","author":"Shen","year":"1998","journal-title":"Cancer Res"},{"key":"10.3816\/CLC.2009.n.015_bib12","first-page":"555","article-title":"Comparison of two human ovarian carcinoma cell lines (A2780\/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene","volume":"16","author":"Yu","year":"2000","journal-title":"Int J Oncol"},{"key":"10.3816\/CLC.2009.n.015_bib13","first-page":"13","article-title":"A nucleotide polymorphism in ERCC1 in human ovarian cancer cell lines and tumor tissues","volume":"382","author":"Yu","year":"1997","journal-title":"Mutat Res"},{"key":"10.3816\/CLC.2009.n.015_bib14","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1053\/j.seminoncol.2003.12.011","article-title":"Molecular predictors of response to chemotherapy in lung cancer","volume":"31","author":"Rosell","year":"2004","journal-title":"Semin Oncol"},{"key":"10.3816\/CLC.2009.n.015_bib15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/carcin\/21.5.965","article-title":"Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells","volume":"21","author":"Duell","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.3816\/CLC.2009.n.015_bib16","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2006.05.8768","article-title":"DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy","volume":"24","author":"Quintela-Fandino","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLC.2009.n.015_bib17","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/bioinformatics\/btg276","article-title":"LDA\u2013a java-based linkage disequilibrium analyzer","volume":"19","author":"Ding","year":"2003","journal-title":"Bioinformatics"},{"key":"10.3816\/CLC.2009.n.015_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/aje\/kwi018","article-title":"ERCC2\/XPD gene polymorphisms and lung cancer: a HuGE review","volume":"161","author":"Benhamou","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.3816\/CLC.2009.n.015_bib19","first-page":"679","article-title":"Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer","volume":"1","author":"Booton","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.3816\/CLC.2009.n.015_bib20","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1002\/cncr.21885","article-title":"Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancer","volume":"106","author":"Booton","year":"2006","journal-title":"Cancer"},{"key":"10.3816\/CLC.2009.n.015_bib21","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","article-title":"XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy","volume":"22","author":"Gurubhagavatula","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.3816\/CLC.2009.n.015_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.lungcan.2003.11.019","article-title":"Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy","volume":"44","author":"Ryu","year":"2004","journal-title":"Lung Cancer"},{"key":"10.3816\/CLC.2009.n.015_bib23","doi-asserted-by":"crossref","first-page":"4939","DOI":"10.1158\/1078-0432.CCR-04-0247","article-title":"Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy","volume":"10","author":"Zhou","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLC.2009.n.015_bib24","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.lungcan.2006.12.002","article-title":"Genetic polymorphisms and treatment response in advanced non-small cell lung cancer","volume":"56","author":"Su","year":"2007","journal-title":"Lung Cancer"},{"key":"10.3816\/CLC.2009.n.015_bib25","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1200\/JCO.2007.11.8547","article-title":"ERCC1 genotype and phenotype in epithelial ovarian cancer identify patients likely to benefit from paclitaxel treatment in addition to platinum-based therapy","volume":"25","author":"Smith","year":"2007","journal-title":"J Clin Oncol"},{"issue":"17","key":"10.3816\/CLC.2009.n.015_bib26","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.1093\/nar\/12.17.6663","article-title":"Codon usage can affect efficiency of translation of genes in Escherichia coli","volume":"12","author":"Robinson","year":"1984","journal-title":"Nucleic Acids Res"},{"key":"10.3816\/CLC.2009.n.015_bib27","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1158\/1078-0432.CCR-04-1953","article-title":"Polymorphisms in ERCC1 and grade 3 or 4 toxicity in non-small cell lung cancer patients","volume":"11","author":"Suk","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLC.2009.n.015_bib28","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/jcb.20711","article-title":"Regulation of DNA repair gene expression in human cancer cell lines","volume":"97","author":"McGurk","year":"2006","journal-title":"J Cell Biochem"},{"key":"10.3816\/CLC.2009.n.015_bib29","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJMoa060570","article-title":"DNA repair by ERCC1 in non-smallcell lung cancer and cisplatin-based adjuvant chemotherapy","volume":"355","author":"Olaussen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.3816\/CLC.2009.n.015_bib30","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/annonc\/mdl300","article-title":"ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine","volume":"17","author":"Ceppi","year":"2006","journal-title":"Ann Oncol"},{"key":"10.3816\/CLC.2009.n.015_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1097-0215(20000920)89:5<453::AID-IJC9>3.0.CO;2-E","article-title":"ERCC1 expression as a molecular marker of cisplatin resistance in human cervical tumor cells","volume":"89","author":"Britten","year":"2000","journal-title":"Int J Cancer"},{"key":"10.3816\/CLC.2009.n.015_bib32","first-page":"2557","article-title":"XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency","volume":"59","author":"Lunn","year":"1999","journal-title":"Cancer Res"},{"key":"10.3816\/CLC.2009.n.015_bib33","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10930-007-9095-y","article-title":"Conformational effects of a common codon 399 polymorphism on the BRCT1 domain of the XRCC1 protein","volume":"26","author":"Monaco","year":"2007","journal-title":"Protein J"},{"key":"10.3816\/CLC.2009.n.015_bib34","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1158\/1078-0432.CCR-06-2543","article-title":"Prospective assessment of XPD Lys-751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer","volume":"13","author":"Giachino","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.3816\/CLC.2009.n.015_bib35","first-page":"3075","article-title":"A polymorphism of the XRCC1 gene predicts for response to platinum based treatment in advanced colorectal cancer","volume":"21","author":"Stoehlmacher","year":"2001","journal-title":"Anticancer Res"},{"key":"10.3816\/CLC.2009.n.015_bib36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1158\/1055-9965.EPI-04-0612","article-title":"Gene-smoking interaction associations for the ERCC1 polymorphisms in the risk of lung cancer","volume":"14","author":"Zhou","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411700900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525730411700900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:56:46Z","timestamp":1761505006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525730411700900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1525730411700900"],"URL":"https:\/\/doi.org\/10.3816\/clc.2009.n.015","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA Repair Gene Polymorphisms Predict Favorable Clinical Outcome in Advanced Non\u2013Small-Cell Lung Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CLC.2009.n.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}